Delayed Graft Function Terminated Phase 2 / 3 Trials for Medroxyprogesterone acetate (DB00603)

Also known as: Graft Function, Delayed

IndicationStatusPhase
DBCOND0004880 (Delayed Graft Function)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01878786A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD KidneysTreatment